EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy

Muyang Yang iD, Jie Zhou, Liseng Lu, Deqiang Deng, Jing Huang, Zijian Tang, Xiujuan Shi, Pui-Chi Lo, Jonathan F Lovell, Yongfa Zheng, Honglin Jin iD

Exploration · 2024-12 · 4 (6)

DOI: 10.1002/exp.20230171 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Exploration, online erschienen am 28.03.2024. Verfasst von Muyang Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedicine and Health and College of Life Science and Technology Huazhong Agricultural University Wuhan China. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 308 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Because therapeutic cancer vaccines can, in theory, eliminate tumor cells specifically with relatively low toxicity, they have long been considered for application in repressing cancer progression. Traditional cancer vaccines containing a single or a few discrete tumor epitopes have failed in the clinic, possibly due to challenges in epitope selection, target downregulation, cancer cell heterogeneity, tumor microenvironment immunosuppression, or a lack of vaccine immunogenicity. Whole cancer cell or cancer membrane vaccines, which provide a rich source of antigens, are emerging as viable alternatives. Autologous and allogenic cellular cancer vaccines have been evaluated as clinical treatments. Tumor cell membranes (TCMs) are an intriguing antigen source, as they provide membrane‐accessible targets and, at the same time, serve as integrated carriers of vaccine adjuvants and other therapeutic agents. This review provides a summary of the properties and technologies for TCM cancer vaccines. Characteristics, categories, mechanisms, and preparation methods are discussed, as are the demonstrable additional benefits derived from combining TCM vaccines with chemotherapy, sonodynamic therapy, phototherapy, and oncolytic viruses. Further research in chemistry, biomedicine, cancer immunology, and bioinformatics to address current drawbacks could facilitate the clinical adoption of TCM vaccines.

Schlagwörter

Stichwörter der Autor:innen

cancer immunotherapycancer vaccinetumor cell membranetumor‐derived extracellular vesicles

Autor:innen und Institutionen

  • College of Biomedicine and Health and College of Life Science and Technology Huazhong Agricultural University Wuhan China.
  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University Guangzhou C…
  • Department of Biomedical Sciences City University of Hong Kong Kowloon Hong Kong China.
  • Department of Biomedical Engineering University at Buffalo State University of New York Buffalo New York USA.
  • Department of Oncology Renmin Hospital of Wuhan University Wuhan China.

ORCID-Profile: Muyang Yang, Honglin Jin

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Yang, M., Zhou, J., Lu, L., Deng, D., Huang, J., Tang, Z., Shi, X., Lo, P. C., Lovell, J. F., Zheng, Y., & Jin, H. (2024). Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy. Exploration, 4(6). https://doi.org/10.1002/exp.20230171

Vancouver

Yang M, Zhou J, Lu L, Deng D, Huang J, Tang Z, et al. Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy. Exploration. 2024;4(6). doi:10.1002/exp.20230171

BibTeX
@article{Yang2024,
  author = {Yang, Muyang and Zhou, Jie and Lu, Liseng and Deng, Deqiang and Huang, Jing and Tang, Zijian and Shi, Xiujuan and Lo, Pui-Chi and Lovell, Jonathan F and Zheng, Yongfa and Jin, Honglin},
  title = {Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy},
  journal = {Exploration},
  year = {2024},
  volume = {4},
  number = {6},
  doi = {10.1002/exp.20230171}
}
Kostenlos starten →